Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "community"

716 News Found

Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment
Medical Device | April 03, 2026

Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment

The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment


Merck secures landmark EU nod for KEYTRUDA in hard-to-treat ovarian cancer
News | April 03, 2026

Merck secures landmark EU nod for KEYTRUDA in hard-to-treat ovarian cancer

Its a major breakthrough for women’s ovarian cancer care in Europe


Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students
Biotech | April 03, 2026

Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students

Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship


Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy
Drug Approval | April 02, 2026

Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy

The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases


Bristol Myers Squibb expands groundbreaking program to close faps in multiple myeloma care
News | April 01, 2026

Bristol Myers Squibb expands groundbreaking program to close faps in multiple myeloma care

The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners


Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology
People | April 01, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River


Rocket Pharma gets FDA nod for first pediatric gene therapy targeting severe LAD-I
R&D | March 29, 2026

Rocket Pharma gets FDA nod for first pediatric gene therapy targeting severe LAD-I

The approval covers pediatric patients without a matched sibling donor for stem cell transplant